MedTrace Logo

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom

NCT04112797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-03-17

No results posted yet for this study

Summary

It is a safety and tolerability study of Allergovac Himenopteros in patients sensitized to Apis mellifera, Polistes Dominula or Vespula spp. To get this aim all adverse reactions will be recorded through the study. In addition, it will be evaluated the treatment efficacy with the re-sting after a year of treatment.

Conditions

  • Allergy to Himenoptera Venom

Interventions

BIOLOGICAL

Allergovac himenoptera

Treatment with allergy vaccine againts Apis mellifera, Vespula spp or Polistes dominula

Sponsors & Collaborators

  • Roxall Medicina España S.A

    lead INDUSTRY

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-23
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04112797 on ClinicalTrials.gov